CARAGLIA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 11.343
EU - Europa 10.422
AS - Asia 1.663
OC - Oceania 18
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 9
Totale 23.476
Nazione #
US - Stati Uniti d'America 11.302
IE - Irlanda 3.457
UA - Ucraina 1.567
IT - Italia 1.467
GB - Regno Unito 1.367
DE - Germania 896
SE - Svezia 488
CN - Cina 487
SG - Singapore 483
FI - Finlandia 449
TR - Turchia 343
GR - Grecia 280
FR - Francia 260
VN - Vietnam 138
BE - Belgio 75
KR - Corea 63
CA - Canada 40
PK - Pakistan 38
IN - India 37
CZ - Repubblica Ceca 28
NL - Olanda 25
JP - Giappone 17
AU - Australia 14
IR - Iran 14
PL - Polonia 14
EU - Europa 10
MY - Malesia 10
ES - Italia 9
BR - Brasile 7
PT - Portogallo 7
RU - Federazione Russa 7
TW - Taiwan 7
HK - Hong Kong 6
MK - Macedonia 5
AT - Austria 4
ID - Indonesia 4
IL - Israele 4
NZ - Nuova Zelanda 4
RO - Romania 4
SC - Seychelles 4
ZA - Sudafrica 4
IQ - Iraq 3
PH - Filippine 3
BG - Bulgaria 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
RS - Serbia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
QA - Qatar 1
SY - Repubblica araba siriana 1
Totale 23.476
Città #
Dublin 3.448
Jacksonville 2.424
Chandler 1.974
Wilmington 633
Chicago 536
Princeton 515
Medford 433
Ann Arbor 386
Boardman 354
Falls Church 351
Caserta 348
Singapore 277
Roxbury 271
San Mateo 254
Bremen 233
New York 218
Woodbridge 198
Beijing 141
Ashburn 139
Dong Ket 138
Cambridge 130
Naples 122
Des Moines 104
Mountain View 85
Napoli 75
Brussels 73
Düsseldorf 65
Nanjing 59
Seoul 49
Helsinki 48
Norwalk 45
Aversa 44
Jinan 43
Houston 41
Los Angeles 33
Milan 31
Munich 31
Auburn Hills 30
Rome 30
Brno 25
Latina 24
Shenyang 23
Venice 23
Tianjin 16
Campodarsego 15
Elora 15
Kunming 15
Nanchang 15
Washington 15
Lappeenranta 13
Redwood City 13
San Nicola la Strada 13
Seattle 13
Hebei 12
Haikou 11
London 11
Ningbo 11
Stuttgart 11
Lucca 10
Montréal 10
Mumbai 10
Salerno 10
San Felice A Cancello 10
Taiyuan 10
Bahawalpur 9
Groningen 9
Guangzhou 9
Hangzhou 8
Avellino 7
Boydton 7
Cava Dei Tirreni 7
Dearborn 7
Fairfield 7
Lanzhou 7
Ottawa 7
Seregno 7
Taizhou 7
Xi'an 7
Zhengzhou 7
Amsterdam 6
Bologna 6
Changsha 6
Lissone 6
San Giuseppe Vesuviano 6
Shanghai 6
Taipei 6
Berlin 5
Gragnano 5
San Giorgio a Cremano 5
Scafati 5
Colle di Val d'Elsa 4
Delhi 4
Frattaminore 4
Gunzenhausen 4
Nottingham 4
Palermo 4
Parma 4
Puchong Batu Dua Belas 4
San Giorgio Del Sannio 4
Siena 4
Totale 14.977
Nome #
Mi-RNA-888-5p Is Involved in S-Adenosylmethionine Antitumor Effects in Laryngeal Squamous Cancer Cells 1.307
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 155
LA S-ADENOSILMETIONINA SINERGIZZZA CON LA DOXORUBICINA NELLA INIBIZIONE PROLIFERATIVA DI CELLULE DI CARCINOMA MAMMARIO ATTRAVERSO L'INDUZIONE DI PROGRAMMI DI MORTE CELLULARE PROGRAMMATA 153
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 104
USO DEI BISFOSFONATI PER LA PREPARAZIONE DI FORMULAZIONI FARMACEUTICHE PER IL TRATTAMENTO DEI SINTOMI ASSOCIATI A DOLORE NEUROPATICO 102
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 100
S-ADENOSYLMETHIONINE-MEDIATED APOPTOSIS IS POTENTIATED BY AUTOPHAGY INHIBITION INDUCED BY CHLOROQUINE IN HUMAN BREAST CANCER CELLS 96
Impiego di ligandi di natura peptidica e non peptidica del recettore UT dell'Urotensina-II quali marcatori di differenziazione del carcinoma prostatico umano. 93
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage 92
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 90
Micrornas in prostate cancer: an overview 89
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 88
Carbon nanotubes: Properties, biomedical applications, advantages and risks in patients and occupationally-exposed workers 87
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 86
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 85
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors 84
Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL) 83
Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento 83
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 82
EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches 82
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 82
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. 80
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 79
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 79
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 77
Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics 77
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 74
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 73
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 73
Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress 72
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 71
Mitochondria as playmakers of apoptosis, autophagy and senescence 71
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 70
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells. 69
Uso di bifosfonati per la preparazione di formulazioni farmaceutiche per il trattamento dei sintomi associati a dolore neuropatico. 69
Expression and localization of serine protease Htra1 in neuroblastoma: Correlation with cellular differentiation grade 68
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 68
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview 67
Tuberculous Lymphadenitis in Southern Italy: Clinical Aspects and Treatment Perspectives 67
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 67
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death 67
L’Apparato Respiratorio 67
Il donatore di metili S-adenosilmetionina potenzia l'effetto apoptotico della doxorubicina nelle cellule di carcinoma mammario 67
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 67
Two different serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients 66
The role of tissue microarray in the era of target-based agents. 65
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 65
Synthetic miR-34a mimics as a novel therapeutic agent for Multiple Myeloma: in vitro and in vivo evidence. 65
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 65
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 65
S-Adenosylmethionine and tyrosol protect HepG2 cells from alcohol-induced oxidative damage 65
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 65
Protective effect of tyrosol and S-adenosylmethionine against ethanol-induced oxidative stress of Hepg2 cells involves Sirtuin 1, P53 and Erk1/2 signaling 65
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 64
The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein 64
Gene interference strategies as a new tool for the treatment of prostate cancer 64
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 64
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review) 64
Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells 63
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 63
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 63
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 62
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells. 62
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC). 62
R115777 (Zarnestra((R)))/Zoledronic acid (Zometa((R))) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation 62
Bioactive peptides in cancer: therapeutic use and delivery strategies. 62
Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells. 62
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 61
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 61
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma 61
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 61
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 61
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 60
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 60
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 60
Synergistic effect of the methyl donor s-adenosylmethionine and doxorubicin in cg5 breast cancer cells 60
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 60
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 60
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 59
Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells. 59
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 59
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo article 59
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 59
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 58
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 58
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. 58
A case of clear renal cell cancer associated to meningioma and verrucous carcinoma of frontal region in an old patient 58
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 58
Mitogen-activated protein kinases and asthma 57
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 57
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 57
What is the purpose of launching the Translational Medicine Reports journal? 57
The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity 57
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 57
Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy 56
Erlotinib: early clinical development in brain cancer. 56
SELF-ASSEMBLING NANOPARTICLES FOR THE RELEASE OF BISPHOSPHONATES IN THE TREATMENT OF HUMAN CANCERS. 56
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? 56
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 56
Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges. 55
Totale 8.256
Categoria #
all - tutte 100.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.724 0 0 57 67 437 40 522 141 229 93 91 47
2020/20213.575 324 28 407 185 523 60 497 380 97 465 370 239
2021/20224.004 340 159 280 160 1.198 60 98 119 142 196 282 970
2022/20237.437 765 225 391 698 678 654 17 432 3.239 61 143 134
2023/20242.771 230 107 164 225 915 249 40 69 44 46 180 502
2024/2025193 76 117 0 0 0 0 0 0 0 0 0 0
Totale 24.479